Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase.
Hofland J, Hofland LJ, van Koetsveld PM, Steenbergen J, de Herder WW, van Eijck CH, de Krijger RR, van Nederveen FH, van Aken MO, de Groot JW, Links TP, de Jong FH, Feelders RA. Hofland J, et al. Among authors: de jong fh, de herder ww, de groot jw, de krijger rr. Orphanet J Rare Dis. 2013 Sep 13;8:142. doi: 10.1186/1750-1172-8-142. Orphanet J Rare Dis. 2013. PMID: 24034279 Free PMC article.
Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane.
Willemsen AECAB, de Geus-Oei LF, de Boer M, Tol J, Kamm Y, de Jong PC, Jonker MA, Vos AH, Grootjans W, de Groot JWB, Mulder SF, Aarntzen EHJG, Gerritsen WR, van Herpen CML, van Erp NP. Willemsen AECAB, et al. Target Oncol. 2018 Oct;13(5):641-648. doi: 10.1007/s11523-018-0596-8. Target Oncol. 2018. PMID: 30259313
Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanoma.
Ter Maat LS, De Mooij RAJ, Van Duin IAJ, Verhoeff JJC, Elias SG, Leiner T, van Amsterdam WAC, Troenokarso MF, Arntz ERAN, Van den Berkmortel FWPJ, Boers-Sonderen MJ, Boomsma MF, Van den Eertwegh FJM, de Groot JW, Hospers GAP, Piersma D, Vreugdenhil A, Westgeest HM, Kapiteijn E, De Wit AA, Blokx WAM, Van Diest PJ, De Jong PA, Pluim JPW, Suijkerbuijk KPM, Veta M. Ter Maat LS, et al. Among authors: de groot jw. Sci Rep. 2024 Dec 30;14(1):31668. doi: 10.1038/s41598-024-81188-2. Sci Rep. 2024. PMID: 39738216 Free PMC article.
Corrigendum to "Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry" [Eur. J. Cancer 212, 2024, 115056].
Özkan A, Kapiteijn E, van den Bos F, Aarts MJB, van den Berkmortel FWPJ, Blank CU, Bloem M, Blokx WAM, Boers-Sonderen MJ, Bonenkamp JJ, van den Eertwegh AJM, de Groot JWB, Haanen JB, Holtslag CE, Hospers GAP, Piersma D, van Rijn RS, Stevense-den Boer AM, Suijkerbuijk KPM, van der Veldt AAM, Vreugdenhil G, Wouters MWJM, Portielje JEA, de Glas NA. Özkan A, et al. Among authors: de groot jwb. Eur J Cancer. 2024 Dec 26;216:115194. doi: 10.1016/j.ejca.2024.115194. Online ahead of print. Eur J Cancer. 2024. PMID: 39732138 No abstract available.
Perspectives of the medical oncologist regarding adjuvant chemotherapy for pancreatic cancer: An international expert survey and case vignette study.
Biesma NC, Graus MUJE, Cirkel GA, Besselink MG, de Groot JWB, Koerkamp BG, Herbschleb KH, Los M, Verdonk RC, Wilmink JW, Cervantes A, Valle JW, Valkenburg-van Iersel LBJ, Froeling FEM, Molenaar IQ, Daamen LA, de Vos-Geelen J, van Santvoort HC; Dutch Pancreatic Cancer Group. Biesma NC, et al. Among authors: de groot jwb. Eur J Surg Oncol. 2024 Dec 12;51(3):109544. doi: 10.1016/j.ejso.2024.109544. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39689462 Free article.
First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases: Post Hoc Analysis of the CAIRO5 Randomized Clinical Trial.
Bond MJG, Bolhuis K, Loosveld OJL, de Groot JWB, Droogendijk H, Helgason HH, Hendriks MP, Klaase JM, Kazemier G, Liem MSL, Rijken AM, Verhoef C, de Wilt JHW, de Jong KP, Gerhards MF, van Amerongen MJ, Engelbrecht MRW, van Lienden KP, Hermans JJ, Molenaar IQ, Grünhagen DJ, de Valk B, Haberkorn BCM, Kerver ED, Erdkamp F, van Alphen RJ, Mathijssen-van Stein D, Komurcu A, May AM, Swijnenburg RJ, Punt CJA; Dutch Colorectal Cancer Group. Bond MJG, et al. Among authors: de groot jwb. JAMA Oncol. 2024 Nov 21:e245174. doi: 10.1001/jamaoncol.2024.5174. Online ahead of print. JAMA Oncol. 2024. PMID: 39570583
Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry.
Özkan A, Kapiteijn E, van den Bos F, Aarts MJB, van den Berkmortel FWPJ, Blank CU, Bloem M, Blokx WAM, Boers-Sonderen MJ, Bonenkamp JJ, van den Eertwegh AJM, de Groot JWB, Haanen JB, Holtslag CE, Hospers GAP, Piersma D, van Rijn RS, Stevense-den Boer AM, Suijkerbuijk KPM, van der Veldt AAM, Vreugdenhil G, Wouters MWJM, Portielje JEA, de Glas NA. Özkan A, et al. Among authors: de groot jwb. Eur J Cancer. 2024 Nov;212:115056. doi: 10.1016/j.ejca.2024.115056. Epub 2024 Sep 30. Eur J Cancer. 2024. PMID: 39368226 Free article.
Reply to: 'Enhancing patient-centered care and addressing psychosocial needs in colorectal cancer: The role of the ABCRC tool'.
Thomassen BJM, Kimman ML, Somers AMJ, Ponds RWHM, Dekker JWT, van Leiden BL, Vink GR, de Groot JWB, Melenhorst J, Reynders KMMW, Gielen CMJ, Weerts THA, Lutke Holzik MF, van Kuijk SMJ, Gidding-Slok AHM, Breukink SO. Thomassen BJM, et al. Among authors: de groot jwb. Eur J Surg Oncol. 2024 Jul 20:108552. doi: 10.1016/j.ejso.2024.108552. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39074994 No abstract available.
Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma.
van Duin IAJ, Schuiveling M, Ter Maat LS, Veta M, van Eijs MJM, Verheijden RJ, van den Berkmortel FWPJ, Boers-Sonderen MJ, Hospers GAP, Labots M, de Groot JWB, Kapiteijn E, Piersma D, Vreugdenhil G, Westgeest H, Schrader AMR, van Diest PJ, Blokx WAM, Suijkerbuijk KPM. van Duin IAJ, et al. Among authors: de groot jwb. Immunooncol Technol. 2024 Jun 12;24:100714. doi: 10.1016/j.iotech.2024.100714. eCollection 2024 Dec. Immunooncol Technol. 2024. PMID: 39045171 Free PMC article.
Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma.
van Duin IAJ, Schuiveling M, Ter Maat LS, van Amsterdam WAC, van den Berkmortel F, Boers-Sonderen M, de Groot JWB, Hospers GAP, Kapiteijn E, Labots M, Piersma D, Schrader AMR, Vreugdenhil G, Westgeest H, Veta M, Blokx WAM, van Diest PJ, Suijkerbuijk KPM. van Duin IAJ, et al. Among authors: de groot jwb. Eur J Cancer. 2024 Sep;208:114190. doi: 10.1016/j.ejca.2024.114190. Epub 2024 Jun 30. Eur J Cancer. 2024. PMID: 38991284 Free article.
222 results